Wells Fargo & Company VYNE THERAPEUTICS INC Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024
Number of Shares
65
Previous 174 62.64%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
N/A
-109 Reduced 62.64%
65 $0
Q1 2024

May 10, 2024
BUY
N/A
2 Added 1.16%
174 $0
Q4 2023

Feb 09, 2024
BUY
N/A
67 Added 63.81%
172 $0
Q3 2023

Nov 13, 2023
BUY
N/A
16 Added 17.98%
105 $0
Q2 2023

Aug 15, 2023
BUY
N/A
2 Added 2.3%
89 $0
Q1 2023

May 12, 2023
BUY
N/A
87 New
87 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email